Monoamine Reuptake Inhibitors in Parkinson's Disease

The motor manifestations of Parkinson's disease (PD) are secondary to a dopamine deficiency in the striatum. However, the degenerative process in PD is not limited to the dopaminergic system and also affects serotonergic and noradrenergic neurons. Because they can increase monoamine levels thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Huot, Philippe, Fox, Susan H., Brotchie, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355567/
https://www.ncbi.nlm.nih.gov/pubmed/25810948
http://dx.doi.org/10.1155/2015/609428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355567/
https://www.ncbi.nlm.nih.gov/pubmed/25810948
http://dx.doi.org/10.1155/2015/609428

Ejemplares similares